MiP2014: Difference between revisions
From Bioblast
(Created page with "[http://www.mitophysiology.org '''<big>MiP2014: Mitochondrial Physiology - a Point/Counterpoint Meeting</big>'''] The Mitochondrial Physiology Society, Obergurgl, Tyrol, Austria...") |
No edit summary |
||
| Line 29: | Line 29: | ||
Members (confirmed): | Members (confirmed): | ||
* Ali Sameh S, Helmy Institute of Medical Sciences, Giza, Egypt | * Ali Sameh S, Helmy Institute of Medical Sciences, Giza, Egypt | ||
* Borutaite Vilma, Lithuanian University of Health Sciences Kaunas, LT | * Borutaite Vilma, Lithuanian University of Health Sciences Kaunas, LT | ||
* Dela Flemming, University of Copenhagen, DK | * Dela Flemming, University of Copenhagen, DK | ||
* Elmér Eskil, Lund University, SE | * Elmér Eskil, Lund University, SE | ||
* Koopman Werner J, Radboud Univ Nijmegen Medical Centre, NL | * Koopman Werner J, Radboud Univ Nijmegen Medical Centre, NL | ||
* Ojuka Edward, University of Cape Town, South Africa | * Ojuka Edward, University of Cape Town, South Africa | ||
* Wei Yau-Huei, Mackay Medical College, New Taipei City, Taiwan | * Wei Yau-Huei, Mackay Medical College, New Taipei City, Taiwan | ||
Members (invited): | Members (invited): | ||
* Chakrabarti Sasanka, Institute of Post-graduate Medical Education & Research, Kolkatta, India | * Chakrabarti Sasanka, Institute of Post-graduate Medical Education & Research, Kolkatta, India | ||
* Chen Quan, Chinese Academy of Sciences, Nankai University, Beijing | * Chen Quan, Chinese Academy of Sciences, Nankai University, Beijing | ||
* Haas Richard H, University of California San Diego, CA, USA | * Haas Richard H, University of California San Diego, CA, USA | ||
* Hickey Anthony J, University of Auckland, NZ | * Hickey Anthony J, University of Auckland, NZ | ||
* Neufer P Darrel, East Carolina University, Greenville, NC, US | * Neufer P Darrel, East Carolina University, Greenville, NC, US | ||
* Perry Christopher G, York University, Toronto, Canada | * Perry Christopher G, York University, Toronto, Canada | ||
* Rossignol Rodrigue, Université Victor Segalen-Bordeaux, FR | * Rossignol Rodrigue, Université Victor Segalen-Bordeaux, FR | ||
* Tanaka Masashi, Toyko Metropolitan Institute of Gerontology, JP | * Tanaka Masashi, Toyko Metropolitan Institute of Gerontology, JP | ||
* Vercesi Anibal E, State University of Campinas, Sao Paulo, Brazil | * Vercesi Anibal E, State University of Campinas, Sao Paulo, Brazil | ||
* Zorzano Antonio, Universitat de Barcelona, Spain | * Zorzano Antonio, Universitat de Barcelona, Spain | ||
Revision as of 21:09, 1 September 2013
MiP2014: Mitochondrial Physiology - a Point/Counterpoint Meeting
The Mitochondrial Physiology Society, Obergurgl, Tyrol, Austria. 2014-Sep-08 to 12
Programme structure
A. Mitochondrial respiratory control
- A1. mtDNA, mt-phenotype and disease – is there biochemical and molecular-genetic evidence to explain observed associations?
- A2. Fission and fusion, mitochondrial structure and function - is there a tight connection?
- A3. Mitochondrial density and normalization of respiration – is there a general biochemical or molecular marker?
- A4. Biochemical reserve capacity, respiratory control ratios and coupling efficiency – are conventional concepts inconsistent?
B. Experimental protocols in mitochondrial biochemistry
- B1. Incubation media for mt-preparations and experimental temperature in functional studies of mammalian mitochondria – guided by concept or merely tradition?
- B2. Intracellular oxygen pressure versus oxygen regimes in studies of ROS production and respiration - are mitochondria sources or sinks of ROS?
- B3. Quantitative measurement of mt-membrane potential - potentiometric/fluorometric.
- B4. Instrumental platforms in mitochondrial physiology – industrial presentations.
C. Towards quality assurance
- C1. Do blood cells versus muscle biopsies provide valid models for diagnosis of mitochondrial pathologies?
- C2. Integrity of mitochondrial preparations – is a consensus possible on quality control criteria?
- C3. Availability and quality control of chemicals used in mitochondrial research – who controls?
- C4. Standards for the diagnosis of mitochondrial pathologies – a challenge for collaboration with mitochondrial organizations?
International programme committee
Chair:
- Gnaiger Erich, Medical University Innsbruck, AT. - [email protected]
Members (confirmed):
- Ali Sameh S, Helmy Institute of Medical Sciences, Giza, Egypt
- Borutaite Vilma, Lithuanian University of Health Sciences Kaunas, LT
- Dela Flemming, University of Copenhagen, DK
- Elmér Eskil, Lund University, SE
- Koopman Werner J, Radboud Univ Nijmegen Medical Centre, NL
- Ojuka Edward, University of Cape Town, South Africa
- Wei Yau-Huei, Mackay Medical College, New Taipei City, Taiwan
Members (invited):
- Chakrabarti Sasanka, Institute of Post-graduate Medical Education & Research, Kolkatta, India
- Chen Quan, Chinese Academy of Sciences, Nankai University, Beijing
- Haas Richard H, University of California San Diego, CA, USA
- Hickey Anthony J, University of Auckland, NZ
- Neufer P Darrel, East Carolina University, Greenville, NC, US
- Perry Christopher G, York University, Toronto, Canada
- Rossignol Rodrigue, Université Victor Segalen-Bordeaux, FR
- Tanaka Masashi, Toyko Metropolitan Institute of Gerontology, JP
- Vercesi Anibal E, State University of Campinas, Sao Paulo, Brazil
- Zorzano Antonio, Universitat de Barcelona, Spain
